Latest Breaking News On - Patrick perez - Page 3 : comparemela.com

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMyriam mendilaPatrick perezSarah fakihDennis riedlCorporate communicationsExchange commissionCurevac corporate services gmbCurevac incChief development officerJunior manager publicVice president corporate communicationsCurevac manufacturing gmbhCurevac swissCurevac corporate services gmbhCurevac belgium

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesMyriam mendilaSarah fakihPatrick perezCurevac incCurevac corporate services gmbCorporate communicationsNews networkChief development officerAbout curevacCurevac media contactJunior manager public relationscurevacVac investor relations contactVice president corporate communicationsInvestor relationscurevacLooking statements curevac

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesPatrick perezAlexander zehnderDennis riedlSarah fakihThaminda ramanayakeBiomarin pharmaceuticalsUniversity of rochester strong medical centerExchange commissionCurevac corporate services gmbBerea collegeCorporate communicationsUniversity of rochester simon school businessClinical trial supply agreement centerCurevac incChief business officer

EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update | Company Announcement

Investegate announcements from EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

United statesUnited kingdomFederal republic of germanyPatrick perezAlexander zehnderSarah fakihPierre kemulaThaminda ramanayakeRegional courtGerman federal courtRna vaccine programBiomarin pharmaceuticalsExchange commissionGerman federal patent courtCurevac management teamDistrict court

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Issuer: CureVac / Key word: Annual Results CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update 24.04.2024 / 13:06.

United statesUnited kingdomFederal republic of germanySarah fakihThaminda ramanayakePierre kemulaPatrick perezAlexander zehnderUniversity of rochester simon school businessClinical trial supply agreement centerCurevac incExchange commissionCorporate developmentSeasonal flu programGerman federal patent courtCorporate communications